Anika Therapeutics Inc (ANIK)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose

Finanzdaten der Anika Therapeutics Inc-Aktie (ANIK)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-12-31	2025-09-30	2025-06-30	2025-03-31	2024-12-31
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	10.06% 30.61	27.82	28.22	26.17	-1.29
Cost Of Revenue	6.52% 11.44	12.23	13.86	11.49	-23.86
Gross Profit	23.07% 19.18	15.58	14.36	14.68	22.57
Operating Expenses	1.51% 18.53	18.82	18.54	18.96	-5.253
Benefits Costs and Expenses	0.67% 29.85	30.05	32.19	30.04	-29.85
Costs And Expenses	1.51% 18.53	18.82	18.54	18.96	-5.253
Depreciation and Amortization	5.25% 1.318	1.391	1.28	1.383	1.56
Operating Income/Loss	119.98% 0.646	-3.233	-4.18	-4.284	27.82
Income/Loss From Continuing Operations Before Tax	134.17% 0.764	-2.236	-3.966	-3.869	28.56
Income Tax Expense/Benefit, Deferred	933.33% -0.025	0.003	-0.003	0.018	0.234
Income Tax Expense/Benefit	210.44% -1.037	0.939	0.681	0.089	2.87
Income/Loss From Continuing Operations After Tax	156.72% 1.801	-3.175	-4.647	-3.958	25.69
Income/Loss From Discontinued Operations, Net Of Tax	278.46% -1.508	0.845	0.677	-0.915	-
Net Income/Loss	112.58% 0.293	-2.33	-3.97	-4.873	-21.86
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	200.00% 0.001	-0.001	-	-	-
Basic Average Shares	100.15% -0.022	14.42	14.36	14.30	-0.048
Diluted Average Shares	100.15% -0.022	14.42	14.52	14.30	-0.048
Basic Earnings Per Share	112.50% 0.02	-0.16	-0.28	-0.34	-1.49
Diluted Earnings Per Share	112.50% 0.02	-0.16	-0.28	-0.34	-1.49
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

ELAN

$22.94

1.15%

RGC

$23.23

3.21%

RDY

$14.13

1.53%

NBIX

$129.78

1.57%

VTRS

$13.51

2.10%

UTHR

$536.12

0.62%